We are proud that MedAtlas, our joint venture partnership with MedAxiom, has been featured in a new leadership article published by the Journal of the American College of Cardiology. The article recognizes MedAtlas as one of the organizations leading the advancement of cardiovascular care by helping health systems develop high‑quality, high‑value cardiovascular (CV) ASCs.
CV ASCs continue to gain attention as more procedures move safely and efficiently into the ambulatory space. Strong clinical outcomes, lower costs, and the need to expand capacity are driving health systems to evaluate new models of care that improve access and patient flow. The JACC article highlights this momentum and underscores the importance of experienced partners who understand both ASC operations and the clinical and regulatory complexity of cardiovascular care. MedAtlas is featured as one of those partners, bringing the specialized expertise needed to build successful CV ASC programs.
We are honored to see this work recognized as we continue supporting organizations in developing safe, scalable CV ASCs backed by rigorous clinical standards and strong operational performance.
Read the full article here.
Further Reading:
